Enforcement record
Criminal Accusation disclosure naming セイルインターナショナル株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Criminal Accusation
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
10 March 2017
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Completed archive verified
- Captured: Jul 12, 2026, 03:33 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
The source links remain available without purchase in the collapsed section below. The paid report consolidates all included URLs and review records into one print-ready document.
Paid report (sample available)
One-time purchasePreview the internal-submission report layout for セイルインターナショナル株式会社
First review the exact document sections and A4 print layout with entirely fictitious data. On the next page, review the included fields, value, and price before deciding whether to purchase.
- Layout suitable for 1 enforcement record currently shown for this target
- Source, preservation-status, and reviewer-field examples
This target currently has saved Kiroku information; the sample shows where preservation details appear.
Same layout, with entirely fictitious data. No payment required; opens in a new tab.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- セイルインターナショナル株式会社Japanese onlyOriginal: セイルインターナショナル株式会社
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices医薬品医療機器等法
- Action type
- Criminal Accusation告発
- Action date
- 10 March 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品・医療機器
Violation
It is suspected that the actions of the accused company violate Article 23-2, Paragraph 1; Article 23-2-3, Paragraph 1; and Article 55, Paragraph 2, which is applied mutatis mutandis under Article 64 of the Act against Unjustifiable Premiums and Misleading Representations, and also violate Articles 84, Item 4; 84, Item 18; and 86, Paragraph 1, Item 4 of the same Act.
Show original Japanese text
被告発会社の行為が、医薬品医療機器等法第23条の2第1項、第23条の2の3第1項及び第64条で準用する第55条第2項に違反し、第84条第4号及び第18号並びに第86条第1項第4号に該当する疑いがある。
Compliance context
HighThe authority announced a criminal accusation or referral based on the disclosed facts.
Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.
Escalate for legal review and check whether later public records changed the status of the matter.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive
- Extracted at
- 2026-04-24T23:35:45.154+00:00
- Evidence checked
- 2026-04-24T23:35:45.154+00:00
- Archive captured
- 2026-07-12T06:33:04.892176+00:00
Show audit JSON
{
"record": {
"id": "0e9c6062-6ae3-48a7-9436-c36c4b997fe9",
"url": "https://regbase.jp/en/enforcement/other-seiruintanasiyonaru-20170310",
"company_name_original": "セイルインターナショナル株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "医薬品医療機器等法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "告発",
"en": "Criminal Accusation"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (セイルインターナショナル株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "High",
"actionMeaning": "The authority announced a criminal accusation or referral based on the disclosed facts.",
"practicalNote": "Escalate for legal review and check whether later public records changed the status of the matter.",
"lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-seiruintanasiyonaru-20170310",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000154531.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/8ef975a77chf0grk",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000154531.html",
"archiveCapturedAt": "2026-07-12T06:33:04.892176+00:00",
"extractedAt": "2026-04-24T23:35:45.154+00:00",
"translatedAt": "2026-05-01T06:50:47.746+00:00",
"evidenceCheckedAt": "2026-04-24T23:35:45.154+00:00",
"generatedAt": "2026-09-08T09:43:20.520Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.